Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells
- PMID: 3531380
- PMCID: PMC2188409
- DOI: 10.1084/jem.164.4.1129
Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells
Abstract
This study identifies defects in the early stages of lymphopoiesis that may contribute to the abnormalities in the development and/or function of peripheral T and B lymphocytes in mice homozygous for the motheaten (me/me) and viable motheaten (mev/mev) mutations. The results indicate that in me/me and mev/mev mice prothymocytes in bone marrow are present in essentially normal numbers, as determined by intrathymic injection, but apparently lack the ability to home effectively to the thymus, as determined by intravenous transfer; early B lineage cells in bone marrow, identified by the B220 antigen, are markedly depleted, including immature B cells (sIg+), pre-B cells (cIg+, sIg-), and pro-B cells (B220+, cIg-, sIg-); TdT+ bone marrow cells, especially a subset that expresses the B220 B lineage antigen, are markedly depleted by two weeks of age; normal numbers of TdT+ thymocytes are present during the first 3 wk of postnatal life, but rapidly decrease thereafter. The results further indicate that neither the defective thymus homing capacity of prothymocytes nor the deficiency of TdT+ bone marrow cells is due to autoantibodies. The possible relationship of the defective development of lymphoid precursor cells to the premature onset of thymic involution and to the abnormalities of peripheral T and B lymphocytes in me/me and mev/mev mice is discussed; as are the results of in vitro studies (presented in a companion paper), which suggest that a primary defect in the stromal microenvironment of the bone marrow is responsible for the abnormal development of the lymphoid precursor cells.
Similar articles
-
Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer.J Exp Med. 1987 Oct 1;166(4):1162-7. doi: 10.1084/jem.166.4.1162. J Exp Med. 1987. PMID: 3498788 Free PMC article.
-
Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro.J Immunol. 1987 Jun 1;138(11):3590-7. J Immunol. 1987. PMID: 3584969
-
Localization of prothymocytes from wild-type and viable motheaten mice following intravenous injection into irradiated adoptive recipients.Cell Immunol. 1994 Feb;153(2):344-55. doi: 10.1006/cimm.1994.1033. Cell Immunol. 1994. PMID: 8118868
-
Molecular basis of the motheaten phenotype.Immunol Rev. 1994 Apr;138:185-206. doi: 10.1111/j.1600-065x.1994.tb00852.x. Immunol Rev. 1994. PMID: 8070815 Review.
-
Development and functional properties of thymic and extrathymic T lymphocytes.Crit Rev Immunol. 2008;28(5):441-66. doi: 10.1615/critrevimmunol.v28.i5.40. Crit Rev Immunol. 2008. PMID: 19166388 Review.
Cited by
-
Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes.Proc Natl Acad Sci U S A. 1989 Aug;86(16):6279-82. doi: 10.1073/pnas.86.16.6279. Proc Natl Acad Sci U S A. 1989. PMID: 2668962 Free PMC article.
-
Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.J Exp Med. 1996 Aug 1;184(2):457-63. doi: 10.1084/jem.184.2.457. J Exp Med. 1996. PMID: 8760799 Free PMC article.
-
Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer.J Exp Med. 1987 Oct 1;166(4):1162-7. doi: 10.1084/jem.166.4.1162. J Exp Med. 1987. PMID: 3498788 Free PMC article.
-
Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.J Exp Med. 1995 Jun 1;181(6):2077-84. doi: 10.1084/jem.181.6.2077. J Exp Med. 1995. PMID: 7539038 Free PMC article.
-
Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.Immunol Res. 2006;35(1-2):127-36. doi: 10.1385/IR:35:1:127. Immunol Res. 2006. PMID: 17003515 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials